Veterinary Medicines

Masti Veyxym intramammális szuszpenzió szarvasmarha részére

Authorised
  • Chymotrypsin
  • ALPHATOCOPHEROL ACETATE
  • Retinol palmitate
  • Papain
  • Trypsin
Download as PDF

Product identification

Medicine name:
Masti Veyxym intramammális szuszpenzió szarvasmarha részére
Active substance:
  • Chymotrypsin
  • ALPHATOCOPHEROL ACETATE
  • Retinol palmitate
  • Papain
  • Trypsin
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Chymotrypsin
    8.00
    milligram(s)
    /
    10.00
    gram(s)
  • ALPHATOCOPHEROL ACETATE
    120.00
    milligram(s)
    /
    10.00
    gram(s)
  • Retinol palmitate
    10000.00
    international unit(s)
    /
    1.00
    gram(s)
  • Papain
    4.00
    milligram(s)
    /
    10.00
    gram(s)
  • Trypsin
    8.00
    milligram(s)
    /
    10.00
    gram(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Milk
        12
        hour
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD03BA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Available in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx-Pharma B.V.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."